Add-on Azilect Safe and Effective in Levodopa-treated PD Patients, Phase 3 Trial in Japan Shows

Using Azilect (rasagiline) as an add-on therapy to levodopa was safe and improved motor function over one year in Parkinson’s patients with off periods, according to a Phase 3 trial in Japan. The study, “Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease,” was published in the Journal of Neural … Continue reading Add-on Azilect Safe and Effective in Levodopa-treated PD Patients, Phase 3 Trial in Japan Shows